In line with this, various other ligand-based CAR-T cells are being introduced, including granulocyte-monocyte colony stimulating factor (GM-CSF) receptor (GMR) CAR-T cells and FLT3L CAR-T cells in AML.37 This evidence concerns the gene FLT3LG and acute myeloid leukemia.